Company intelligence / Profile preview
GI Cell
Songpa-gu, Seoul, South Koreagi-cell.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
GI Cell has demonstrated preclinical superiority of its mass culture and engineering platforms for allogeneic NK and regulatory T-cell therapies. The company’s lead candidates are advancing toward IND-enabling studies with a focus on cancer immunotherapy. No published clinical results yet.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Allogeneic NK cell therapy (Natural Killer cells)Treg cell therapy (Regulatory T cells)CAR-NK cell therapy (Chimeric Antigen Receptor NK cells)Multi-valent sub-unit vaccines
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Optieum Biotechnologies (Japan)—scFv antibody discovery collaboration for next-gen CAR-NK developmentHK inno.N—collaboration on next-generation CAR-NK therapyLetter of intent with Turkish company to export allogeneic NK technology.
Beyond the preview
Go deeper on GI Cell.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GI Cell.